Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltidine versus hydromorphone for postoperative PCIA after hip replacement in elderly patients
ChiCTR2400093014Phase 4Not yet recruiting
- Sponsor
- Tianjin Jizhou District People's Hospital
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oseltidine and hydromorphone in postoperative pain (2 arms), sponsored by Tianjin Jizhou District People's Hospital. Primary endpoints: NRS score, Area under the curve for NRS (static and dynamic) and 1 more. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oseltidinehydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400093014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093014.